top of page

Valorization & Socio-economic Impact

Our lab believes in actively valorizing and translating our research deliverables to maximize socio-economic impact of our research. This entails exciting opportunities like translating our research toward novel clinical trials, patenting our novel inventions, and exploring industrial collaborations. In long-term our lab also hopes to pursue technology transfer opportunities as well as spin-off creation, efforts for which are already in motion.

Patenting & Inventions:

Click on above image to go to a YouTube video introducing our sFIS biomarker assay!

Novel blood-based biomarkers for immuno-oncology: Our lab created a “first-in-class” serum functional immunodynamics status (sFIS) assay, wherein in vitro assessment of serum-induced myeloid NFkB and/or interferon (IFN) response-signaling can be performed to “mimic” in situ patient’s serum immune-biology. This assays's performance in anticipating patient prognosis and immunotherapy-relevant stratification has been confirmed for patients with ovarian cancer, lung cancer and breast cancer.
>> For patent information, click here!
>> For simplified technology offering statement, click here!​

  • KU Leuven
  • Department of Cellular & Molecular Medicine
  • X
  • LinkedIn
  • download
  • bluesky

© 2025 by Prof. Abhishek D. Garg. Ceated with Wix.com

bottom of page